Taconic Biosciences and Cyagen Biosciences Announce

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
65
Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership

RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership.  Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to premium custom model design and generation services backed by comprehensive capabilities and cutting-edge, fully-licensed technologies.

Custom animal models play a critical role in new drug discovery as biological systems that provide critical insight into the dynamic between a potential therapeutic and a living organism.

Combining over twenty years of experience, the industry’s most extensive model generation technology portfolio, and seamless integration to downstream premium custom breeding solutions, Taconic is recognized for creating complex genetically engineered mice and rats for biomedical research. Cyagen entered the industry in 2005 and has gained a strong following for providing model and vector generation services. Through the alliance, Cyagen customers gain access to expanded expertise, comprehensive program management, state-of-the art technologies, pricing flexibility, and faster project timelines through a single point of contact, ensuring the best solution for each unique project. 

“Taconic will provide the best solution to every model generation customer through access to scientific experts who generate superior designs using state-of-the-art methods.  Through this alliance with Cyagen, Taconic can now offer customers the broadest range of options in the industry in line with market demand,” shared Dr. Robert Rosenthal, CEO of Taconic Biosciences. 

“Cyagen Biosciences provides researchers with the highest quality animal models possible to ensure ground breaking discoveries.  Researchers are increasingly demanding higher quality animal model services at lower costs. Through this new alliance with Taconic, Cyagen will offer researchers even higher quality animal models, with new options available to minimize or eliminate quarantine and other added costs, while providing production capabilities that exceed previous standards and expectations,” commented Dr. Reza Rezaei, VP of Sales of Cyagen Biosciences.

To learn more about Taconic Biosciences’ products and services, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com .

To learn more about Cyagen Biosciences, please call 800-921-8930 (from 8 a.m. - 6 p.m. PST) or +1-408-969-0306 (Int'l) in the US, 800-793-45 or +32-28085797 (Int'l) in Europe, or email service@cyagen.com .

About Cyagen Biosciences, Inc. Cyagen Biosciences is the world's largest provider of custom-engineered mouse & rat models. Cyagen is world renowned for its quality, money back guarantee, and cost-effective prices. Headquartered in California, with locations in Germany, Japan, and China, Cyagen provides researchers from around the world with transgenic, knockout, knock-in, CRISPR, and ES-cell based models and also offers a comprehensive series of stem cell products for research use, including cell lines, media, and differentiation kits. From vector and strategy design to animal model creation, cryopreservation, and breeding, Cyagen offers complete outsourcing for all animal model needs.

About Taconic Biosciences, Inc. Taconic Biosciences is a global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal model solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Taconic is a fully-licensed provider of rodent model generation services and has twenty years of model design experience , providing gene inactivation, gene mutation, replacement and humanization, transgene expression, RNAi, and gene editing via CRISPR/Cas9 technologies to ensure that the right tools are leveraged for each specific customer project.  Complimenting this expertise is Taconic’s unique capability of providing a seamless transition from model design to breeding and colony management , thus offering customers a complete solution.  Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact: Kelly Owen Grover Director of Marketing Communications Taconic Biosciences (518) 697-3824 kelly.grover@taconic.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 85

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 165

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 148

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Titans Rally: Stock Highlights You Can't Miss Today

Updated Category News Views 204

Market Overview Recent trading sessions in the U.S. saw mixed results. While the Dow Jones Industrial Average experienced a slight decline, the S&P 500 showed minimal movement. In contrast, the tech-centered Nasdaq showed a modest uptick as many companies presented their earnings. Federal Reserve Updates The Federal Reserve's decision to hold interest rates steady at...

Continue Reading
Investment Growth: Alphabet Stock's Journey Over Two Decades

Updated Category News Views 265

Understanding the Performance of Alphabet Stock Alphabet (NASDAQ: GOOGL) has consistently demonstrated remarkable growth, outpacing the market by an impressive 9.36% on an annualized basis. This translates to an average annual return of 18.3%, showcasing the company's ability to thrive even amid challenging economic conditions. With a market capitalization soaring to...

Continue Reading
Palantir Technologies Expands with 26 Partnerships in 15 Sectors

Updated Category News Views 885

Palantir's Remarkable Growth Journey Palantir Technologies Inc (NASDAQ: PLTR) has been making waves in the enterprise software landscape. In merely ten months, the company has successfully formed 26 partnerships across 15 different sectors, a feat that extends its reach well beyond its traditional defense-oriented image. This surge in collaboration indicates its...

Continue Reading
Bitcoin Market Dynamics Shift Amidst Emerging Trends

Updated Category News Views 148

Bitcoin Market Dynamics Shift Amidst Emerging Trends The financial markets are currently navigating through a phase of cautious optimism, with the leading indices showing modest gains. A notable exception to this trend is Bitcoin, which has recently displayed some volatility. After a significant breakout, Bitcoin encountered a sudden reverse, leading to concerns of a...

Continue Reading
Stifel Financial Corp. Announces Cash Dividends for Investors

Updated Category News Views 129

Stifel Financial Corporation's Dividend Announcement Stifel Financial Corp. announces a substantial cash dividend for its common stock shareholders, declaring a payout of $0.46 per share. This announcement comes as part of the company's regular financial strategy aimed at rewarding its shareholders. The payment is scheduled for September 16, with shareholders on record as...

Continue Reading